4 Results for "

C-33A

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "C-33A" in MCE Product Catalog:

Cat. No.: HY-108636
CAS No.: 1036069-26-7
Purity:  99.42%
RETRA is a RIPK1/RIPK3/MLKL and p73 activator. RETRA mediates plasma membrane disruption, induces ROS accumulation, triggers early mitochondrial hyperpolarization, and synergistically drives necroptosis. RETRA inhibits cancer cells carrying mutant p53 via a p73-dependent salvage pathway. RETRA can be used in research related to cervical cancer and cancers with mutant p53 .
loading...
    loading...
Cat. No.: HY-168180
CAS No.: 2975172-98-4
Target:  

Wee1

Research Areas:  

Cancer

WEE1-IN-11 (Compound 13) is a potent CDK2 inhibitor with an IC50 of 2.0 nM. WEE1-IN-11 inhibits NCI–H446, A427, OVCAR3, C33A,and WiDr cells with IC50s of 93.9, 34.5, 86.7, 23.1, and 85 nM, respectively .
loading...
    loading...
Cat. No.: HY-173133
CAS No.: 3063469-69-9
Target:  

Autophagy Atg7

Research Areas:  

Cancer

Antitumor agent-199 (Compound 4b) is an antitumor agent. Antitumor agent-199 exhibits significant antiproliferative activity against multiple tumor cell lines. Antitumor agent-199 can induce autophagy in cancer cells via the ATG5/ATG7 pathway and can be used in the study of cancer .
loading...
    loading...
Cat. No.: HY-P11814
Synonyms: Cyclic TMTP1
cTMTP1 (Cyclic TMTP1) is the cyclic form of TMTP1 (HY-P11815). TMTP1 is a tumor-targeting peptide that selectively targets highly metastatic tumor cells. The cTMTP1-based [ 68Ga]Ga-DOTA-cTMTP1 probe is used for visualization of hepatocellular carcinoma. cTMTP1 can form a 68Ga-DOTA radiotracer that accumulates in highly metastatic cervical cancer cells and is used for microPET tumor visualization. cTMTP1 is applicable to research related to hepatocellular carcinoma and cervical cancer .
loading...
    loading...